Catalyst Wire Dossier Catalyst Wire Dossier

MRKAd5 Gag/Pol/Nef vaccine

· Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MRKAd5 Gag/Pol/Nef vaccine, covering 2011-07-07 to 2011-07-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Safety, Tolerability, and Immunogenicity of the MRKAd5 Gag/Pol/Nef Vaccine in Healthy Adults (V520-016) [Phase 1]

See pricing